Is Applied Genetic Technologies Corporation (AGTC) a Buy, Sell, or Hold?
NASDAQ : AGTC
Applied Genetic Technologies Corporation — Insider Trades
$0.3936 USD
$0 (0.0%)
- Volume
- 764.53K
- Average Volume
- 1.28M
- Market Capitalization
- $0
- P/E Ratio
- -0.25
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.83
- Year Low
- $0.23
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.97
Insider Activity Summary (Last 12 Months)
Insiders Buying
8
Insiders Selling
25
Amount of Insider Selling
$1.67M
AGTC Insider Buying/Selling by Quarter
AGTC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Robinson James A. Jr. | director | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| VANLENT ANNE | director | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Rosen James | director | 2022-11-30 | U-Tender | 0 | 2022-12-01 |
| Rosen James | director | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Aliski William | director | 2022-11-30 | U-Tender | 0 | 2022-12-01 |
| Aliski William | director | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| HURWITZ EDWARD | director | 2022-11-30 | U-Tender | 0 | 2022-12-01 |
| HURWITZ EDWARD | director | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Hashad Yehia | director | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Koenig Scott | director | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Koenig Scott | director | 2022-11-30 | U-Tender | 0 | 2022-12-01 |
| Reynolds Gerald Anthony | officer: Chief Accounting Officer | 2022-11-30 | U-Tender | 0 | 2022-12-01 |
| Reynolds Gerald Anthony | officer: Chief Accounting Officer | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Scaria Abraham | officer: Chief Scientific Officer | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Potter Stephen W | officer: Chief Business Officer | 2022-11-30 | U-Tender | 0 | 2022-12-01 |
| Potter Stephen W | officer: Chief Business Officer | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| DOyley-Gay Hope | officer: General Counsel | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Schneider Susan | officer: Chief Medical Officer | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Lieber Jonathan I | officer: Chief Financial Officer | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Washer Susan B. | officer: President and CEO | 2022-11-30 | U-Tender | 0 | 2022-12-01 |
| Washer Susan B. | officer: President and CEO | 2022-11-30 | D-Return | 0 | 2022-12-01 |
| Reynolds Gerald Anthony | officer: Chief Accounting Officer | 2022-08-21 | A-Award | 0 | 2022-08-24 |
| DOyley-Gay Hope | officer: General Counsel | 2022-08-21 | A-Award | 0 | 2022-08-24 |
| Potter Stephen W | officer: Chief Business Officer | 2022-08-21 | A-Award | 0.4 | 2022-08-24 |
| Potter Stephen W | officer: Chief Business Officer | 2022-08-21 | A-Award | 0 | 2022-08-24 |
| Scaria Abraham | officer: Chief Scientific Officer | 2022-08-21 | A-Award | 0 | 2022-08-24 |
| Schneider Susan | officer: Chief Medical Officer | 2022-08-21 | A-Award | 0 | 2022-08-24 |
| Lieber Jonathan I | officer: Chief Financial Officer | 2022-08-21 | A-Award | 0.4 | 2022-08-24 |
| Lieber Jonathan I | officer: Chief Financial Officer | 2022-08-21 | A-Award | 0 | 2022-08-24 |
| Washer Susan B. | director, officer: President and CEO | 2022-08-21 | A-Award | 0.4 | 2022-08-24 |
| Washer Susan B. | officer: President and CEO | 2022-08-21 | A-Award | 0 | 2022-08-24 |
| Potter Stephen W | officer: Chief Business Officer | 2022-07-01 | S-Sale | 0.7745 | 2022-07-01 |
| Potter Stephen W | officer: Chief Business Officer | 2022-06-30 | S-Sale | 0.7745 | 2022-07-01 |
| Reynolds Gerald Anthony | officer: Chief Accounting Officer | 2022-05-27 | S-Sale | 0.8452 | 2022-05-31 |
| Washer Susan B. | director, officer: President and CEO | 2022-02-18 | M-Exempt | 0.35 | 2022-02-22 |
| Washer Susan B. | director, officer: President and CEO | 2022-02-18 | S-Sale | 2.18 | 2022-02-22 |
| Washer Susan B. | director, officer: President and CEO | 2022-02-18 | M-Exempt | 0.35 | 2022-02-22 |
| DOyley-Gay Hope | officer: General Counsel | 2021-12-13 | A-Award | 2.02 | 2021-12-15 |
| DOyley-Gay Hope | officer | 2021-12-13 | 0 | 2021-12-15 | |
| Scaria Abraham | officer: Chief Scientific Officer | 2021-12-06 | A-Award | 1.98 | 2021-12-07 |
| Scaria Abraham | officer | 2021-12-06 | 0 | 2021-12-07 | |
| Robinson James A. Jr. | director | 2021-11-30 | A-Award | 2.17 | 2021-12-02 |
| Robinson James A. Jr. | director: | 2021-11-30 | 0 | 2021-12-02 | |
| VANLENT ANNE | director | 2021-11-30 | A-Award | 2.17 | 2021-12-02 |
| Rosen James | director | 2021-11-30 | A-Award | 2.17 | 2021-12-02 |
| Magovcevic-Liebisch Ivana | director | 2021-11-30 | A-Award | 2.17 | 2021-12-02 |
| Koenig Scott | director | 2021-11-30 | A-Award | 2.17 | 2021-12-02 |
| HURWITZ EDWARD | director | 2021-11-30 | A-Award | 2.17 | 2021-12-02 |
| Hashad Yehia | director | 2021-11-30 | A-Award | 2.17 | 2021-12-02 |
| Aliski William | director | 2021-11-30 | A-Award | 2.17 | 2021-12-02 |
| Schneider Susan | officer: Chief Medical Officer | 2021-11-08 | A-Award | 2.76 | 2021-11-16 |
| Schneider Susan | officer | 2021-11-08 | 0 | 2021-11-16 | |
| Washer Susan B. | director, officer: President and CEO | 2021-11-01 | M-Exempt | 3.5 | 2021-11-03 |
| Washer Susan B. | director, officer: President and CEO | 2021-11-01 | M-Exempt | 3.5 | 2021-11-03 |
| Lieber Jonathan I | officer: Chief Financial Officer | 2021-09-20 | A-Award | 3.3 | 2021-09-21 |
| Lieber Jonathan I | officer | 2021-09-20 | 0 | 2021-09-21 | |
| Hashad Yehia | director | 2021-08-16 | A-Award | 3.42 | 2021-08-18 |
| Hashad Yehia | director: | 2021-08-16 | 0 | 2021-08-18 | |
| Potter Stephen W | officer: Chief Business Officer | 2021-08-15 | F-InKind | 3.58 | 2021-08-17 |
| Reynolds Gerald Anthony | officer: Chief Accounting Officer | 2021-08-05 | A-Award | 3.7 | 2021-08-06 |
| Potter Stephen W | officer: Chief Business Officer | 2021-07-27 | A-Award | 3.74 | 2021-07-29 |
| Washer Susan B. | director, officer: President and CEO | 2021-07-27 | A-Award | 3.74 | 2021-07-29 |
| Potter Stephen W | officer: Chief Business Officer | 2021-06-17 | A-Award | 0 | 2021-06-21 |
| Reynolds Gerald Anthony | officer: Chief Accounting Officer | 2021-06-09 | 0 | 2021-06-17 | |
| Reynolds Gerald Anthony | officer: Chief Accounting Officer | 2021-06-09 | 5.5 | 2021-06-17 | |
| Reynolds Gerald Anthony | officer: Chief Accounting Officer | 2021-06-09 | 3.28 | 2021-06-17 | |
| VANLENT ANNE | director | 2020-12-16 | A-Award | 4.72 | 2020-12-18 |
| Rosen James | director | 2020-12-16 | A-Award | 4.72 | 2020-12-18 |
| Magovcevic-Liebisch Ivana | director | 2020-12-16 | A-Award | 4.72 | 2020-12-18 |
| HURWITZ EDWARD | director | 2020-12-16 | A-Award | 4.72 | 2020-12-18 |
| Aliski William | director | 2020-12-16 | A-Award | 4.72 | 2020-12-18 |
| Koenig Scott | director | 2020-12-16 | A-Award | 4.72 | 2020-12-18 |
| Potter Stephen W | officer: VP and Chief Business Officer | 2020-08-15 | F-InKind | 5.77 | 2020-08-18 |
| Shearman Mark S | officer: Chief Scientific Officer | 2020-08-15 | F-InKind | 5.77 | 2020-08-18 |
| Potter Stephen W | officer: VP and Chief Business Officer | 2020-08-05 | A-Award | 5.5 | 2020-08-07 |
| Sullivan William A. | officer: Chief Financial Officer | 2020-08-05 | A-Award | 5.5 | 2020-08-07 |
| Washer Susan B. | director, officer: President and CEO | 2020-08-05 | A-Award | 5.5 | 2020-08-07 |
| Shearman Mark S | officer: Chief Scientific Officer | 2020-08-05 | A-Award | 5.5 | 2020-08-07 |
| Krol Patrick Johan Hendrik | 10 percent owner | 2019-12-26 | S-Sale | 5.24 | 2019-12-30 |
| VANLENT ANNE | director | 2019-12-04 | A-Award | 3.02 | 2019-12-06 |
| Rosen James | director | 2019-12-04 | A-Award | 3.02 | 2019-12-06 |
| Magovcevic Ivana | director | 2019-12-04 | A-Award | 3.02 | 2019-12-06 |
| HURWITZ EDWARD | director | 2019-12-04 | A-Award | 3.02 | 2019-12-06 |
| Aliski William | director | 2019-12-04 | A-Award | 3.02 | 2019-12-06 |
| Koenig Scott | director | 2019-12-04 | A-Award | 3.02 | 2019-12-06 |
| Krol Patrick Johan Hendrik | 10 percent owner | 2019-11-19 | P-Purchase | 2.79 | 2019-11-26 |
| Krol Patrick Johan Hendrik | 10 percent owner | 2019-11-18 | 0 | 2019-11-26 | |
| Krol Patrick Johan Hendrik | 10 percent owner | 2019-11-18 | 0 | 2019-11-26 | |
| Washer Susan B. | director, officer: President and CEO | 2019-09-18 | M-Exempt | 3.5 | 2019-09-20 |
| Washer Susan B. | director, officer: President and CEO | 2019-09-18 | M-Exempt | 3.5 | 2019-09-20 |
| Krex Brian | officer: General Counsel | 2019-08-15 | A-Award | 3 | 2019-08-19 |
| Shearman Mark S | officer: Chief Scientific Officer | 2019-08-15 | A-Award | 3 | 2019-08-19 |
| Shearman Mark S | officer: Chief Scientific Officer | 2019-08-15 | A-Award | 0 | 2019-08-19 |
| Potter Stephen W | officer: VP and Chief Business Officer | 2019-08-15 | A-Award | 3 | 2019-08-19 |
| Potter Stephen W | officer: VP and Chief Business Officer | 2019-08-15 | A-Award | 0 | 2019-08-19 |
| Sullivan William A. | officer: Chief Financial Officer | 2019-08-15 | A-Award | 3 | 2019-08-19 |
| Washer Susan B. | director, officer: President and CEO | 2019-08-15 | A-Award | 3 | 2019-08-19 |
| Heah Theresa | officer: Chief Medical Officer | 2019-07-29 | A-Award | 3.91 | 2019-07-31 |
| Heah Theresa | officer | 2019-07-29 | 0 | 2019-07-31 | |
| Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 2019-07-29 | A-Award | 3.91 | 2019-07-31 |